new meningitis b jab - effective against 80 per cent of strains found in europe - could be approved for use by the spring .
it is the most common form of bacterial meningitis and the toughest challenge for scientists because it is hard to diagnose and swift to kill .
there is currently no vaccine to protect against meningococcal b in this country .